{"title":"FIGO 1988与2009对子宫内膜癌分期的比较研究","authors":"A. E. Tahaoglu, Sait Bakir, E. Erdogdu, C. Dane","doi":"10.17795/IJCP-4986","DOIUrl":null,"url":null,"abstract":"Objectives: The aim of this study was to investigate the benefits of the newly revised “The international federation of gynecology and obstetrics (FIGO), 2009” sytem and whether there was a difference in new system comparison to 1988 F˙IGO staging sytem for endometrial carcinoma. Methods: A total of 132 patients who underwent complete surgical staging for endometrial cancer were enrolled retrospectively. Those patients’ overall survival and disease free survival were compared with 1988 and 2009 staging system. Results: The five year overall survival (OS) rates for patients with 1988 FIGO stage 1 and 2 were 97% and 100%, respectively. In 2009 system,theOSratesfor1and2were97% and100%,respectively. Therewasnostatisticallysignificantdifferencesbetweenstage1and stage 2 for OS rates in 1988 and 2009 as well. Conclusions: Thenewly revisedsystem couldbe lesscomplex forunderstanding, but itdoes notdiscriminatesurvival ratesbetter, especially in earlier stages. A new staging system and uniform surgical staging could be discussed.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A Comparative Study of FIGO 1988 Versus 2009 Staging for Endometrial Carcinoma\",\"authors\":\"A. E. Tahaoglu, Sait Bakir, E. Erdogdu, C. Dane\",\"doi\":\"10.17795/IJCP-4986\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: The aim of this study was to investigate the benefits of the newly revised “The international federation of gynecology and obstetrics (FIGO), 2009” sytem and whether there was a difference in new system comparison to 1988 F˙IGO staging sytem for endometrial carcinoma. Methods: A total of 132 patients who underwent complete surgical staging for endometrial cancer were enrolled retrospectively. Those patients’ overall survival and disease free survival were compared with 1988 and 2009 staging system. Results: The five year overall survival (OS) rates for patients with 1988 FIGO stage 1 and 2 were 97% and 100%, respectively. In 2009 system,theOSratesfor1and2were97% and100%,respectively. Therewasnostatisticallysignificantdifferencesbetweenstage1and stage 2 for OS rates in 1988 and 2009 as well. Conclusions: Thenewly revisedsystem couldbe lesscomplex forunderstanding, but itdoes notdiscriminatesurvival ratesbetter, especially in earlier stages. A new staging system and uniform surgical staging could be discussed.\",\"PeriodicalId\":73510,\"journal\":{\"name\":\"Iranian journal of cancer prevention\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian journal of cancer prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17795/IJCP-4986\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian journal of cancer prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17795/IJCP-4986","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Comparative Study of FIGO 1988 Versus 2009 Staging for Endometrial Carcinoma
Objectives: The aim of this study was to investigate the benefits of the newly revised “The international federation of gynecology and obstetrics (FIGO), 2009” sytem and whether there was a difference in new system comparison to 1988 F˙IGO staging sytem for endometrial carcinoma. Methods: A total of 132 patients who underwent complete surgical staging for endometrial cancer were enrolled retrospectively. Those patients’ overall survival and disease free survival were compared with 1988 and 2009 staging system. Results: The five year overall survival (OS) rates for patients with 1988 FIGO stage 1 and 2 were 97% and 100%, respectively. In 2009 system,theOSratesfor1and2were97% and100%,respectively. Therewasnostatisticallysignificantdifferencesbetweenstage1and stage 2 for OS rates in 1988 and 2009 as well. Conclusions: Thenewly revisedsystem couldbe lesscomplex forunderstanding, but itdoes notdiscriminatesurvival ratesbetter, especially in earlier stages. A new staging system and uniform surgical staging could be discussed.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
